The hype is loud and the money is flowing. But inside healthcare, clinicians wonder if the tech is just a larger-scale rehash ...

Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

A recent federal opinion offers doctors new latitude to invest in healthcare ventures, but financial entanglements can still ...

Overall, 46% of the respondents correctly identified chronic cough. Of these, allergists/immunologists had the highest ...

BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

A new study suggests nitrous oxide may offer a new treatment option for older adults with treatment-resistant depression.

People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved ...

The published dosing standards set the drug-delivery technology on a path toward FDA consideration and eventual use against ...

Short-term exposure to low or high temperatures is linked to an increased likelihood of all-cause and cardiovascular disease ...

Dr Devon S. Conway reflects on revised MS diagnostic criteria enabling earlier diagnosis and promising pipeline therapies.